Ensuring optimal patient outcomes in oncology relies not only on effective therapies but also on systematic approaches to care delivery. Quality Improvement & Safety initiatives focus on enhancing clinical processes, minimizing errors, and standardizing best practices across cancer care settings. By implementing evidence-based protocols, monitoring performance metrics, and conducting regular audits, healthcare teams can identify gaps in care, reduce variability, and improve patient outcomes. Multidisciplinary collaboration among oncologists, nurses, pharmacists, and administrative staff is essential to creating a culture of continuous improvement, where patient safety and treatment effectiveness are prioritized at every stage of care.
The scope of Quality Improvement & Safety extends to patient-centered strategies, including error prevention, risk assessment, and adherence to regulatory standards. Programs often incorporate training, process redesign, and technology integration, such as electronic health records and clinical decision support systems, to enhance accuracy and efficiency. Continuous evaluation of clinical outcomes, patient satisfaction, and adverse events informs refinements in care delivery and policy implementation. By fostering a proactive approach to safety and quality, oncology teams can optimize treatment effectiveness, reduce complications, and enhance the overall patient experience. Integrating these strategies into routine practice ensures that patients receive high-quality, safe, and reliable cancer care, while institutions achieve measurable improvements in performance and outcomes.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Spatial multi-omics inference of diabetes-triggered pancreatic cancer growth: The key role of cholesterol-induced neutrophil extracellular
Guanqun Li, The First Affiliated Hospital of Harbin Medical University, China
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada